EX-FILING FEES 8 tm245976d2_ex-filingfees.htm EX-FILING FEES

Exhibit 107

 

Calculation of Filing Fee Tables

 

Schedule TO-T

 

(Rule 14d-100)

 

CYMABAY THERAPEUTICS, INC.
(Name of Subject Company (Issuer))

 

PACIFIC MERGER SUB, INC.
a wholly owned subsidiary of

 

GILEAD SCIENCES, INC.
(Names of Filing Persons (Offerors))

 

Table 1-Transaction Valuation

 

   Transaction Valuation*   Fee Rate   Amount of Filing Fee** 
Fees to Be Paid  $4,336,360,599.20    0.0001476   $640,046.82 
Fees Previously Paid  $0        $0 
Total Transaction Valuation  $4,336,360,599.20           
Total Fees Due for Filing            $640,046.82 
Total Fees Previously Paid  $0        $0 
Total Fee Offsets            $0 
Net Fee Due            $640,046.82 

 

 

 * Estimated for purposes of calculating the filing fee only. The transaction valuation was calculated as the sum of (i) 114,811,001 outstanding shares of common stock, par value $0.0001 per share (the “Shares”), of CymaBay Therapeutics, Inc. (“CymaBay”) multiplied by $32.50, (ii) 17,339,540 Shares issuable pursuant to outstanding “in-the-money” stock options multiplied by $24.23 (which is $32.50 minus the weighted average exercise price for such options of $8.27 per share), (iii) 461,557 Shares issuable pursuant to restricted stock units with respect to Shares multiplied by $32.50 and (iv) 5,226,628 Shares underlying outstanding warrants to purchase Shares multiplied by $32.50. The calculation of the filing fee is based on information provided by CymaBay as of February 20, 2024.

 

** The filing fee was calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, and Fee Rate Advisory #1 for Fiscal Year 2024, issued August 25, 2023, by multiplying the transaction value by 0.0001476.